Pharmacy Website
Clinic Website
TabletWise.com TabletWise.com
 

Intelligence » Top Posts » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Measles outbreak leads New York county to ban unvaccinated children from public spaces

Tuesday, March 26, 2019 -- Rockland County Executive Ed Day cited a state law, which gives local officials sweeping powers "in the event of reasonable apprehension of immediate danger" to the public.

Dementia Deaths Have Doubled in Two Decades

Thursday, March 28, 2019 -- Alzheimer's disease — the most common form of dementia for which there is no effective conventional treatment or cure — currently affects an estimated 5.8 million Americans,1 up from 5.4 million in 2016. By 2050, that figure is projected to hit 14 million.2 Research3 published in 2014 revealed Alzheimer's had risen to the point of being the third leading cause of death in the U.S.4 For clarification, while the Centers for Disease Control and Prevention (CDC) continues to list Alzheimer's as the sixth leading cause of death in the U.S.,5 this ranking is based on death certificates, and the study in question found Alzheimer's was grossly underreported as a cause of death on death certificates. Recalculations based on the

Ebola Cases in Democratic Republic of Congo Have Surpassed 1,000

Monday, March 25, 2019 -- Ongoing attacks on treatment facilities contribute to the rise in case numbers

A Cheap Diabetes Drug Shows Potential as a Life-Extension Therapy

Monday, March 25, 2019 -- Off-Label Angel investor Ariel Poler thinks he’s discovered a way to live a longer, healthier life — and it’s only costing him $2 a month. Millions of people with diabetes take the drug metformin to help lower their blood sugar levels. But in recent years, Poler and a growing number of Silicon Valley residents have […] The post A Cheap Diabetes Drug Shows Potential as a Life-Extension Therapy appeared first on Futurism.

Michigan measles outbreak rises to 22 cases

Wednesday, March 27, 2019 -- In a follow-up on the measles outbreak in Michigan, state health officials have confirmed 22 total measles cases statewide since March 13, 2019. Oakland County has 21 cases and one case was a Wayne County resident. Infected individuals range in age from 11 to 63. The outbreak that began earlier this month is linked to an ill […] The post Michigan measles outbreak rises to 22 cases appeared first on Outbreak News Today.

Asthma Medicine Xolair Successfully Treats Lung Allergy Due to Fungal Infection in 3 CF Patients, Case Report Shows

Tuesday, March 26, 2019 -- Xolair (omalizumab), a medicine used for allergic asthma and chronic hives, is effective for treating lung allergic reactions caused by fungi in patients with cystic fibrosis (CF), a case report suggests. The study reports three cases of allergic bronchopulmonary aspergillosis in CF patients who were successfully treated with Xolair after conventional therapy with corticosteroids and […] The post Asthma Medicine Xolair Successfully Treats Lung Allergy Due to Fungal Infection in 3 CF Patients, Case Report Shows appeared first on Cystic Fibrosis News Today.

PRM-151 Receives FDA Breakthrough Therapy Designation for IPF Treatment

Wednesday, March 27, 2019 -- The U.S. Food and Drug Administration has granted breakthrough therapy designation to PRM-151, a compound being investigated for the treatment of idiopathic pulmonary fibrosis (IPF). PRM-151 is a recombinant (lab-made) version of the protein pentraxin-2. This protein acts on immune cells called macrophages; it can activate these cells to help resolve scarring — essentially reversing the process […] The post PRM-151 Receives FDA Breakthrough Therapy Designation for IPF Treatment appeared first on Pulmonary Fibrosis News.

The Most Buzzworthy Type 2 Diabetes Drug in Development? Tirzepatide

Monday, March 25, 2019 -- This content originally appeared on diaTribe. Republished with permission.By Jeemin Kwon The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease Clinical Trials Identifier: NCT03730662 Trial name: A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased […]

Americans Are Having Fewer Heart Attacks

Tuesday, March 26, 2019 -- They are also living longer after having a heart attack.

A1c blood test found to be unreliable in diabetes diagnoses

Tuesday, March 26, 2019 -- Research has found that many cases of diabetes are missed when the hemoglobin A1c blood test is used solely to diagnose the disease.

Protein that Drives Cancer Is Potential New Therapeutic Target for Idiopathic Pulmonary Fibrosis, Study Suggests

Monday, March 25, 2019 -- High levels of PD-L1 protein were found in the most aggressive fibroblasts that drive idiopathic pulmonary fibrosis (IPF) progression, making the protein — whose levels are increased in cancer cells to shield a tumor from the immune system — a potential new therapeutic target, a study suggests. The study, “PD-L1 on invasive fibroblasts drives fibrosis […] The post Protein that Drives Cancer Is Potential New Therapeutic Target for Idiopathic Pulmonary Fibrosis, Study Suggests appeared first on Pulmonary Fibrosis News.

Preventing depression in pregnancy: New guidelines

Tuesday, March 26, 2019 -- First-ever recommendations from US Preventive Services Task Force aim to help women who experience depression during pregnancy or after childbirth. The post Preventing depression in pregnancy: New guidelines appeared first on Harvard Health Blog.

Esbriet Safe and Effective for Patients with Advanced Idiopathic Pulmonary Fibrosis, Trial Suggests

Tuesday, March 26, 2019 -- A post-hoc analysis of the Phase 3 RECAP trial shows that long-term treatment with Esbriet (pirfenidone) is safe and similarly effective in patients with advanced idiopathic pulmonary fibrosis (IPF) as in those with less advanced disease. The study, “Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis,” was published in the journal Respiratory Research. Esbriet, […] The post Esbriet Safe and Effective for Patients with Advanced Idiopathic Pulmonary Fibrosis, Trial Suggests appeared first on Pulmonary Fibrosis News.

Early to bed, early to rise: Study confirms the benefits of sleeping early for preventing diabetes

Tuesday, March 26, 2019 -- (Natural News) Your bedtime habits can affect your risk of developing diabetes. A literature review published in the journal Advances in Nutrition finds that going to bed and waking up earlier could help slash the risk of Type 2 diabetes. Earlier studies have suggested that chrono-nutrition, which is the timing of dietary intake, may be... Read More

EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes

Monday, March 25, 2019 -- British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.

African American men respond better to treatments for advanced prostate cancer in clinical trials

Tuesday, March 26, 2019 -- Racial differences have long been evident in prostate cancer statistics. In particular, African American men are diagnosed with prostate cancer more often than white men, and they’re also nearly twice as likely to die of the disease. But new research also shows that African American men who receive the most advanced treatments for late-stage prostate […] The post African American men respond better to treatments for advanced prostate cancer in clinical trials appeared first on Harvard Health Blog.

Does Wealth Affect Who Develops Type 2 Diabetes?

Monday, March 25, 2019 -- Given the recent college admissions scandal, whereby big-name American celebrities and affluent movers and shakers paid “fixers” to get their children into Ivy League schools, would you be surprised to learn that socioeconomic status, or SES, also plays a prominent and problematic role in who might develop type 2 diabetes? Ongoing Research About SES and […]

FDA approves oral testosterone capsule for men with hypogonadism

Wednesday, March 27, 2019 -- The FDA on Wednesday approved testosterone undecanoate in an oral capsule to treat men with certain forms of hypogonadism, the agency announced in a press release.The approval marks the first new oral testosterone replacement product in more than 60 years. The indication is for men with low testosterone levels due to specific medical conditions, such as Klinefelter syndrome or tumors that have damaged the pituitary gland. This oral testosterone undecanoate (Jatenzo, Clarus Therapeutics) should not be used to treat men with “age-related hypogonadism,” in which testosterone levels

UK Hemophilia Care Teams Lack Knowledge on Bleeding Risks in Dental Procedures, Study Suggests

Wednesday, March 27, 2019 -- Hemophilia care providers in the U.K. have insufficient knowledge on how to assess the risk of prolonged bleeding associated with dental procedures, a study has found. The study, “U.K. hemophilia treaters’ knowledge of risk assessment for prolonged bleeding associated with dental procedures,” was published in the journal Special Care in Dentistry. Previous studies revealed that […] The post UK Hemophilia Care Teams Lack Knowledge on Bleeding Risks in Dental Procedures, Study Suggests appeared first on Hemophilia News Today.

Hepatic steatosis common in young adults with life-long HIV

Tuesday, March 26, 2019 -- Thirty-three percent of young adults with HIV since birth or early childhood have hepatic steatosis, a prevalence comparable to older adults with HIV and “significantly higher” than HIV-negative controls, according to research published in The Journal of Infectious Diseases“In this cross-sectional study of young adults with life-long HIV, we identified that one-third of the cohort had evidence of fatty liver using noninvasive transient elastography techniques,” Colleen Hadigan, MD, MPH, a staff clinician in the laboratory of immunoregulation at the National Institute